The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis
Study sponsor: Lipocine Inc. · LPCN
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2021-06-24Actual
Enrollment · participants56Actual
Source updated2023-12-14Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.